Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases
- PMID: 37526671
- DOI: 10.1007/s00198-023-06869-6
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases
Comment on
-
Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis.Arch Osteoporos. 2022 Oct 1;17(1):131. doi: 10.1007/s11657-022-01166-x. Arch Osteoporos. 2022. PMID: 36180610
References
-
- Kumar S, Chang R, Reyes M, Diamond T (2022) Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis. Arch Osteoporos 17:1–4 - DOI
-
- van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Guañabens N, Eastell R, Ralston SH, Carola Zillikens M (2020) Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin Endocrinol Metab 105:1682–1699 - DOI - PubMed
-
- Everts-Graber J, Bonel H, Lehmann D, Gahl B, Häuselmann HJ, Studer U, Ziswiler HR, Reichenbach S, Lehmann T (2022) Incidence of atypical femoral fractures in patients on osteoporosis therapy-a registry-based cohort study. JBMR Plus 6(10):e10681. https://doi.org/10.1002/JBM4.10681 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
